These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22016712)

  • 1. Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration?
    Chiu AS; Gehringer MM; Welch JH; Neilan BA
    Int J Environ Res Public Health; 2011 Sep; 8(9):3728-46. PubMed ID: 22016712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
    Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
    J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
    Cox PA; Banack SA; Murch SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
    Papapetropoulos S
    Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
    Murch SJ; Cox PA; Banack SA
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMAA--an unusual cyanobacterial neurotoxin.
    Vyas KJ; Weiss JH
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():50-5. PubMed ID: 19929732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
    Liu X; Rush T; Zapata J; Lobner D
    Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cycad β-N-methylamino-L-alanine (BMAA), methylazoxymethanol, genotoxicity, and neurodegeneration.
    Spencer PS; Palmer VS; Kisby GE
    Toxicon; 2018 Dec; 155():49-50. PubMed ID: 30316979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of ß-N-methylamino-L-alanine in cyanobacteria and aquatic organisms from waters of Northern Poland; BMAA toxicity studies.
    Błaszczyk A; Siedlecka-Kroplewska K; Woźniak M; Mazur-Marzec H
    Toxicon; 2021 Apr; 194():90-97. PubMed ID: 33610631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.
    Ra D; Sa B; Sl B; Js M; Sj M; DA D; Ew S; O K; Eb B; Ad C; Vx T; Gg G; Pa C; Dc M; Wg B
    Neurotox Res; 2021 Feb; 39(1):81-106. PubMed ID: 33547590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.
    Brownson DM; Mabry TJ; Leslie SW
    J Ethnopharmacol; 2002 Oct; 82(2-3):159-67. PubMed ID: 12241991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor 1 mediates the electrophysiological and toxic actions of the cycad derivative beta-N-Methylamino-L-alanine on substantia nigra pars compacta DAergic neurons.
    Cucchiaroni ML; Viscomi MT; Bernardi G; Molinari M; Guatteo E; Mercuri NB
    J Neurosci; 2010 Apr; 30(15):5176-88. PubMed ID: 20392940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMAA and Neurodegenerative Illness.
    Cox PA; Kostrzewa RM; Guillemin GJ
    Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential Role of BMAA in Neurodegeneration.
    Caller T; Henegan P; Stommel E
    Neurotox Res; 2018 Jan; 33(1):222-226. PubMed ID: 28612294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease?
    Metcalf JS; Codd GA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.
    Scott LL; Downing TG
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29286334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanobacterial Neurotoxin Beta-Methyl-Amino-l-Alanine Affects Dopaminergic Neurons in Optic Ganglia and Brain of
    Brooke-Jones M; Gáliková M; Dircksen H
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30544796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.